Barnard Neal D, Alwarith Jihad, Rembert Emilie, Brandon Liz, Nguyen Minh, Goergen Andrea, Horne Taylor, do Nascimento Gabriel F, Lakkadi Kundanika, Tura Andrea, Holubkov Richard, Kahleova Hana
Physicians Committee for Responsible Medicine, Washington, DC, USA.
Adjunct Faculty, George Washington University School of Medicine and Health Sciences, Washington, DC, USA.
J Am Nutr Assoc. 2022 Feb;41(2):127-139. doi: 10.1080/07315724.2020.1869625. Epub 2021 Feb 5.
Evidence suggests that both Mediterranean and vegan diets improve body weight and cardiometabolic risk factors, but their relative efficacy has not been compared in a randomized trial. In a randomized crossover trial, 62 overweight adults were randomly assigned to a Mediterranean or vegan diet for a 16-week period. Body weight, plasma lipids, blood pressure, and body composition (dual X-ray absorptiometry) were measured. Secondary measures included insulin resistance (Homeostasis Model Assessment, HOMA-IR), oral glucose insulin sensitivity (OGIS), and predicted insulin sensitivity (PREDIM) indices. Thereafter, participants were asked to return to their baseline diets for 4 weeks, after which they began the opposite diet for 16 weeks. The same parameters were measured before and after this 2 16-week period. Overall net weight changes were 0.0 (Mediterranean) and -6.0 kg (vegan), (treatment effect -6.0 kg [95% CI -7.5 to -4.5]; < 0.001). HOMA-IR decreased and OGIS increased on the vegan diet with no significant change on the Mediterranean diet (treatment effect -0.7 [95% CI, -1.8 to +0.4]; = 0.21; and +35.8 mL/min/m [95% CI, +13.2 to +58.3]; = 0.003, respectively). PREDIM did not change significantly in either group. Among participants with no medication changes, total and LDL-cholesterol decreased 18.7 mg/dL (0.5 mmol/L) and 15.3 mg/dL (0.4 mmol/L), respectively, on the vegan diet, compared with no significant change on the Mediterranean diet (treatment effect -15.6 [-24.6 to -6.6]; = 0.001 and -14.8 [-23.5 to -6.2]; = 0.001, respectively); systolic and diastolic blood pressure decreased 9.3 and 7.3 mmHg on the Mediterranean diet, compared with 3.4 and 4.1 mmHg on the vegan diet (treatment effect +5.9 [95% CI +1.0 to +10.9]; = 0.02; and +1.8 [95% CI -4.6 to +8.1]; = 0.58, respectively). A low-fat vegan diet improved body weight, lipid concentrations, and insulin sensitivity, both from baseline and compared with a Mediterranean diet. Blood pressure decreased on both diets, more on the Mediterranean diet. ClinicalTrials.gov number, NCT03698955 https://clinicaltrials.gov/ct2/show/NCT03698955?term=NCT03698955&draw=2&rank=1.
有证据表明,地中海饮食和纯素饮食都能改善体重和心血管代谢风险因素,但在一项随机试验中尚未对它们的相对疗效进行比较。在一项随机交叉试验中,62名超重成年人被随机分配到地中海饮食组或纯素饮食组,为期16周。测量了体重、血脂、血压和身体成分(双能X线吸收法)。次要指标包括胰岛素抵抗(稳态模型评估,HOMA-IR)、口服葡萄糖胰岛素敏感性(OGIS)和预测胰岛素敏感性(PREDIM)指数。此后,参与者被要求恢复其基线饮食4周,之后开始为期16周的相反饮食。在这两个16周期间前后测量相同的参数。总体净体重变化分别为0.0(地中海饮食组)和-6.0千克(纯素饮食组)(治疗效果为-6.0千克[95%CI-7.5至-4.5];<0.001)。纯素饮食组的HOMA-IR降低,OGIS升高,而地中海饮食组无显著变化(治疗效果为-0.7[95%CI,-1.8至+0.4];=0.21;以及+35.8毫升/分钟/米[95%CI,+13.2至+58.3];=0.003)。两组的PREDIM均无显著变化。在未改变用药的参与者中,与地中海饮食组无显著变化相比,纯素饮食组的总胆固醇和低密度脂蛋白胆固醇分别降低了18.7毫克/分升(0.5毫摩尔/升)和15.3毫克/分升(0.4毫摩尔/升)(治疗效果分别为-15.6[-24.6至-6.6];=0.001和-14.8[-23.5至-6.2];=0.001);地中海饮食组的收缩压和舒张压分别降低了9.3和7.3毫米汞柱,而纯素饮食组分别降低了3.4和4.1毫米汞柱(治疗效果分别为+5.9[95%CI+1.0至+10.9];=0.02;以及+1.8[95%CI-4.6至+8.1];=0.58)。低脂纯素饮食从基线开始并与地中海饮食相比,改善了体重、血脂浓度和胰岛素敏感性。两种饮食都能降低血压,地中海饮食降低得更多。ClinicalTrials.gov编号,NCT03698955 https://clinicaltrials.gov/ct2/show/NCT03698955?term=NCT03698955&draw=2&rank=1